Survival Rates of Bone-Implanted Prosthetics in Facial Rehabilitation for Oncology Patients
-
By
-
Oliver Blanshard
-
Sarah Jones
-
Peter M. Clarke
-
Jonathan M. Bernstein
-
September 2, 2026
Clinical Scorecard: Survival Rates of Bone-Implanted Prosthetics in Facial Rehabilitation for Oncology Patients
At a Glance
| Category | Detail |
|---|
| Condition | Bone-anchored implants for facial prosthetic rehabilitation |
| Key Mechanisms | Implant retention provides greater patient satisfaction compared to adhesive retention. |
| Target Population | Adults undergoing oncologic head and neck surgery, primarily with radiation therapy. |
| Care Setting | Oncologic surgical rehabilitation |
Key Highlights
- Study evaluates implant longevity in oncology patients post-surgery.
- Implant survival rates reported above 85% in non-irradiated populations.
- 184 implants analyzed from 51 patients with a mean follow-up of 3.5 years.
- Squamous cell carcinoma was the most frequent histology (41%).
- Majority of patients received radiation therapy.
Guideline-Based Recommendations
Diagnosis
- Assess implant failure through clinical records and radiographic imaging.
Management
- Consider patient comorbidities and smoking status when evaluating implant survival.
Monitoring & Follow-up
- Regular follow-up to document implant presence and assess for failure.
Risks
- Radiation therapy exposure may influence implant survival.
Patient & Prescribing Data
Adults with head and neck oncologic conditions requiring facial prosthetics.
Mean of 3.6 implants per patient, with a median of 3.0 implants.
Clinical Best Practices
- Utilize standardized protocols for patient identification and data collection.
- Incorporate comprehensive follow-up to ensure accurate assessment of implant outcomes.
- Evaluate the impact of radiation therapy on implant longevity.
Related Resources & Content
